Cargando…

Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin

HER2/neu positive breast tumors predict a high mortality and comprise 25%–30% of breast cancer. We have shown that Flavokawain A (FKA) preferentially reduces the viabilities of HER2-overexpressing breast cancer cell lines (i.e., SKBR3 and MCF7/HER2) versus those with less HER2 expression (i.e., MCF7...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jandial, Danielle D., Krill, Lauren S., Chen, Lixia, Wu, Chunli, Ke, Yu, Xie, Jun, Hoang, Bang H., Zi, Xiaolin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5547191/ https://www.ncbi.nlm.nih.gov/pubmed/28335434 http://dx.doi.org/10.3390/molecules22030462

Ejemplares similares

Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis
por: Ji, Tao, et al.
Publicado: (2013)

Dietary feeding of flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice
por: Li, Xuesen, et al.
Publicado: (2014)

The flavokawains: uprising medicinal chalcones
por: Abu, Nadiah, et al.
Publicado: (2013)

Flavokawains A and B in Kava, Not Dihydromethysticin, Potentiate Acetaminophen-Induced Hepatotoxicity in C57BL/6 Mice
por: Narayanapillai, Sreekanth C., et al.
Publicado: (2014)

Kava-Kava in Gonorrhœa
Publicado: (1893)

Kava, Kawa, Kava-Kava—A Powerful Anæsthetic and Spinal Depressant
Publicado: (1886)

Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation
por: Li, Xuesen, et al.
Publicado: (2019)

Cases of Genito-Urinary Diseases Treated by Kava-Kava
por: Phillips, Leslie
Publicado: (1897)

Inflammatory sebotropic reaction associated with kava kava ingestion
por: Brown-Joel, Zoe O., et al.
Publicado: (2018)

Kava : the Pacific drug /
por: Lebot, Vincent
Publicado: (1992)

Toxicokinetics of Kava
por: Rowe, Anthony, et al.
Publicado: (2011)

Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
por: Schwall, RH, et al.
Publicado: (2003)

Serological Her2/neu-determination in patients receiving Herceptin(®)
por: Thomas, A, et al.
Publicado: (2001)

The Potential Utility of Curcumin in the Treatment of HER-2-Overexpressed Breast Cancer: An In Vitro and In Vivo Comparison Study with Herceptin
por: Lai, Hung-Wen, et al.
Publicado: (2012)

Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
por: Menendez, Javier A, et al.
Publicado: (2007)

Kavalactone yangonin induces autophagy and sensitizes bladder cancer cells to flavokawain A and docetaxel via inhibition of the mTOR pathway
por: Liu, Zhongbo, et al.
Publicado: (2017)

Update on HER-2 as a target for cancer therapy: Herceptin in the clinical setting
por: Miles, David W
Publicado: (2001)

Herbicidal Activity of Flavokawains and Related trans-Chalcones against Amaranthus tricolor L. and Echinochloa crus-galli (L.) Beauv.
por: Chotsaeng, Nawasit, et al.
Publicado: (2019)

Reciprocal Regulation of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin-Resistant Breast Cancer
por: Shetty, Praveenkumar K., et al.
Publicado: (2012)

Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
por: Müller, Volkmar, et al.
Publicado: (2018)

Correction: Reciprocal Regulation of Annexin A2 and EGFR with Her-2 in Her-2 Negative and Herceptin-Resistant Breast Cancer
por: Shetty, Praveenkumar K., et al.
Publicado: (2012)

Kinetic Modeling of DUSP Regulation in Herceptin-Resistant HER2-Positive Breast Cancer
por: Buiga, Petronela, et al.
Publicado: (2019)

Flavokawain A Reduces Tumor-Initiating Properties and Stemness of Prostate Cancer
por: Song, Liankun, et al.
Publicado: (2022)

HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer
por: Gijsen, Merel, et al.
Publicado: (2010)

Herceptin (trastuzumab) in patients who overexpress Her-2 and have failed multiple chemotherapy regimens for advanced breast cancer: a pragmatic study
por: Westman, G
Publicado: (2000)

Design, Synthesis and Docking Studies of Flavokawain B Type Chalcones and Their Cytotoxic Effects on MCF-7 and MDA-MB-231 Cell Lines
por: Abu Bakar, Addila, et al.
Publicado: (2018)

Recombinant humanised anti-HER2/neu antibody (Herceptin®) induces cellular death of glioblastomas
por: Mineo, J-F, et al.
Publicado: (2004)

Correction: HER2 Phosphorylation Is Maintained by a PKB Negative Feedback Loop in Response to Anti-HER2 Herceptin in Breast Cancer
por: Gijsen, Merel, et al.
Publicado: (2016)

Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line
por: Ali, Norlaily Mohd, et al.
Publicado: (2016)

The In Vitro and In Vivo Anticancer Properties of Chalcone Flavokawain B through Induction of ROS-Mediated Apoptotic and Autophagic Cell Death in Human Melanoma Cells
por: Hseu, You-Cheng, et al.
Publicado: (2020)

Plant-Made Trastuzumab (Herceptin) Inhibits HER2/Neu+ Cell Proliferation and Retards Tumor Growth
por: Komarova, Tatiana V., et al.
Publicado: (2011)

Kava as a Clinical Nutrient: Promises and Challenges
por: Bian, Tengfei, et al.
Publicado: (2020)

Opportunities and Challenges of Kava in Lung Cancer Prevention
por: Freeman, Breanne, et al.
Publicado: (2023)

Chemoprevention of Urothelial Cell Carcinoma Tumorigenesis by Dietary Flavokawain A in UPII-Mutant Ha-ras Transgenic Mice
por: Liu, Zhongbo, et al.
Publicado: (2022)

Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model
por: Li, Xuesen, et al.
Publicado: (2015)

3, 3′-diindolylmethane Enhances the Effectiveness of Herceptin against HER-2/Neu-Expressing Breast Cancer Cells
por: Ahmad, Aamir, et al.
Publicado: (2013)

Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles
por: Shirshahi, Vahid, et al.
Publicado: (2013)

Suppression of LPS-Induced Inflammation by Chalcone Flavokawain A through Activation of Nrf2/ARE-Mediated Antioxidant Genes and Inhibition of ROS/NFκB Signaling Pathways in Primary Splenocytes
por: Yang, Hsin-Ling, et al.
Publicado: (2020)

Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancer
por: Sassen, Andrea, et al.
Publicado: (2009)

Hepatotoxicity Induced by “the 3Ks”: Kava, Kratom and Khat
por: Pantano, Flaminia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_55culpr4ud7gqh6g9uk384r2a1